Orthofix Intl NV (OFIX) Stock Price, Quote & News

Company Profile

Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and...

Industry: Medical Devices

Sector: Healthcare

Phone: 214 937 2000

Website: orthofix.com

Address:

3451 Plano Parkway, Lewisville, United States

A1FinancialCEOMark Jun. 24 at 1:09 PM

$MDT $ACON The Aclarion Buy Out talk we made a video on, well... is now officially ON. We chose MDT as our pick of the 11 suitors, and NOW here's why we were RIGHT-- Just announced today: Medtronic, Aclarion's CEO Brent Ness, formerly in Medtronic management, to present, & meet-- with $GMED, $OFIX, & $ATEC in CABO tomorrow: Read the full story why top Analysts give Aclarion a $481 pt: https://www.a1loansusa.com/aclarion-at-spine-conference

1 · Reply

IN0V8 Jun. 23 at 4:17 PM

$OFIX Buy Barrington Research initiates coverage with outperform rating Barrington Research initiates coverage with PT $16

0 · Reply

JarvisFlow Jun. 23 at 1:00 PM

Barrington Research updates rating for Orthofix Medical ( $OFIX ) to Outperform, target set at 16.

0 · Reply

JarvisFlow Jun. 6 at 2:10 PM

JMP Securities has adjusted their stance on Orthofix Medical ( $OFIX ), setting the rating to Market Perform.

0 · Reply

valueforme Jun. 2 at 8:14 PM

$OFIX Planning to take another look on this one

0 · Reply

CEOBuysDisclosures May. 13 at 1:20 AM

$OFIX CEO purchased 10,000 shares at $12.54 for a total of $125,400. Calafiore Massimo now owns 234,603 shares. https://ceo-buys.com

0 · Reply

PenkeTrading May. 7 at 11:26 AM

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Orthofix Medical Inc. Is that bullish or bearish? $OFIX #RsiOversold #NASDAQ

0 · Reply

macroaxis May. 7 at 8:21 AM

$OFIX - Implied volatility is down to 1.16 for Orthofix Medical https://www.macroaxis.com/stock-options/OFIX/Orthofix-Medical?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

macroaxis Mar. 27 at 2:34 PM

$OFIX - Pin risk slides as more Orthofix Medical put traders are getting in https://www.macroaxis.com/stock-options/OFIX/Orthofix-Medical?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

NVDAMillionaire Mar. 21 at 6:07 AM

$OFIX Merger with SeaSpine looks promising. Bone growth tech is legit. Watching for Q1 performance and potential entry point. Diversified portfolio gives me confidence in long-term play. high-quality article: https://beyondspx.com/article/orthofix-medical-inc-nasdaq-ofix-a-diversified-powerhouse-in-musculoskeletal-solutions

0 · Reply

Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System

May 6, 2025, 2:39 PM EDT - 7 weeks ago

Orthofix Medical Inc. (OFIX) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:00 AM EDT - 7 weeks ago

Orthofix Reports First Quarter 2025 Financial Results

Mar 19, 2025, 8:00 AM EDT - 3 months ago

Orthofix Receives 510(k) Clearance and CE Mark for TrueLok Elevate Transverse Bone Transport System

Mar 12, 2025, 8:00 AM EDT - 3 months ago

Orthofix Announces Appointment of Vickie Capps to Board of Directors

Mar 3, 2025, 7:00 AM EST - 4 months ago

Orthofix to Participate in the 37th Annual Roth Conference

Feb 25, 2025, 1:40 PM EST - 4 months ago

Orthofix Medical Inc. (OFIX) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 7:00 AM EST - 4 months ago

Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance

Feb 17, 2025, 7:05 AM EST - 4 months ago

Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Feb 5, 2025, 6:57 AM EST - 5 months ago

Top 2 Health Care Stocks That May Crash In February

GMED

Jan 28, 2025, 7:00 AM EST - 5 months ago

Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results

Dec 4, 2024, 3:45 PM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Orthofix Medical Inc. (OFIX) Investors to Inquire about Securities Investigation

Nov 12, 2024, 7:05 AM EST - 8 months ago

Orthofix to Participate in Upcoming Investor Conferences

Nov 10, 2024, 2:21 PM EST - 8 months ago

Orthofix Medical Inc. (OFIX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:05 AM EST - 8 months ago

Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets

Nov 7, 2024, 7:05 AM EST - 8 months ago

Orthofix Announces New Term Loan

Oct 21, 2024, 7:00 AM EDT - 8 months ago

Orthofix to Participate in Stifel 2024 Healthcare Conference

Oct 19, 2024, 11:00 AM EDT - 8 months ago

Orthofix Medical Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Help The Schall Law Firm

Oct 19, 2024, 10:45 AM EDT - 8 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Orthofix

Oct 17, 2024, 11:00 AM EDT - 9 months ago

Orthofix Medical Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Oct 16, 2024, 10:39 AM EDT - 9 months ago

DEADLINE NEXT WEEK: Berger Montague Advises Orthofix Medical (NASDAQ: OFIX) Investors to Contact the Firm Before October 21, 2024

Oct 16, 2024, 12:42 AM EDT - 9 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in Orthofix Medical Inc. Lawsuit – OFIX

Oct 13, 2024, 11:00 AM EDT - 9 months ago

Orthofix Medical Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 10, 2024, 7:00 AM EDT - 9 months ago

Orthofix to Report Third Quarter 2024 Financial Results

Sep 29, 2024, 11:00 AM EDT - 9 months ago

Orthofix Medical Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Encouraged To Contact The Schall Law Firm

Sep 27, 2024, 11:00 AM EDT - 9 months ago

Orthofix Medical Inc Is Being Sued For Violating Securities Laws And Stockholders With Losses Should Contact The Schall Law Firm

A1FinancialCEOMark Jun. 24 at 1:09 PM

1 · Reply

IN0V8 Jun. 23 at 4:17 PM

$OFIX Buy Barrington Research initiates coverage with outperform rating Barrington Research initiates coverage with PT $16

0 · Reply

JarvisFlow Jun. 23 at 1:00 PM

Barrington Research updates rating for Orthofix Medical ( $OFIX ) to Outperform, target set at 16.

0 · Reply

JarvisFlow Jun. 6 at 2:10 PM

JMP Securities has adjusted their stance on Orthofix Medical ( $OFIX ), setting the rating to Market Perform.

0 · Reply

valueforme Jun. 2 at 8:14 PM

$OFIX Planning to take another look on this one

0 · Reply

CEOBuysDisclosures May. 13 at 1:20 AM

$OFIX CEO purchased 10,000 shares at $12.54 for a total of $125,400. Calafiore Massimo now owns 234,603 shares. https://ceo-buys.com

0 · Reply

PenkeTrading May. 7 at 11:26 AM

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Orthofix Medical Inc. Is that bullish or bearish? $OFIX #RsiOversold #NASDAQ

0 · Reply

macroaxis May. 7 at 8:21 AM

$OFIX - Implied volatility is down to 1.16 for Orthofix Medical https://www.macroaxis.com/stock-options/OFIX/Orthofix-Medical?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

macroaxis Mar. 27 at 2:34 PM

$OFIX - Pin risk slides as more Orthofix Medical put traders are getting in https://www.macroaxis.com/stock-options/OFIX/Orthofix-Medical?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

NVDAMillionaire Mar. 21 at 6:07 AM

0 · Reply

hohumStocks Mar. 19 at 1:38 PM

$OFIX This stock is unknown to people. Profitable, and today announced FDA approval. Nobody knows of it. $SLS $ATOS $MRKR $NRSN my other favorites.

0 · Reply

JarvisFlow Feb. 26 at 5:27 PM

Canaccord Genuity updates rating for Orthofix Medical ($OFIX) to Buy, target set at 24.

0 · Reply

JarvisFlow Feb. 26 at 4:57 PM

Roth MKM updates rating for Orthofix Medical ($OFIX) to Buy, target set at 22.

0 · Reply

d_risk Feb. 25 at 3:54 PM

$OFIX - Orthofix Medical Inc. Common Stock (DE) - 10K - Updated Risk Factors OFIX's 2025 10-K Risk Factors reveal integration challenges with SeaSpine, increased regulatory scrutiny, new litigation risks, and heightened competition. Enhanced focus on cybersecurity, ESG pressures, and potential financial impacts from inventory and foreign exchange risks. #Risk https://d-risk.ai/OFIX/10-K/2025-02-25

0 · Reply

thebigdipper0 Jan. 7 at 10:02 PM

$OFIX About that time to buy back in

0 · Reply

mkeytail Nov. 19 at 6:00 PM

$OFIX always believe

0 · Reply

d_risk Nov. 7 at 4:15 PM

$OFIX - 10Q - New Risk Factors New risks include litigation from terminated executives and financial strain from a $275M credit facility with strict covenants; compliance failures could severely impact financial health. https://d-risk.ai/OFIX/10-Q/2024-11-07

0 · Reply

thebigdipper0 Nov. 6 at 8:15 PM

$OFIX is made in the USA. Its competitors are not. Hello tariffs :)

0 · Reply

PenkeTrading Nov. 6 at 12:45 PM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Orthofix Medical Inc. Is that bullish or bearish? $OFIX #RsiOverbought #NASDAQ

0 · Reply

newsfile_corp Oct. 21 at 8:01 PM

https://nfne.ws/221040 $OFIX @BGandG_Law #Banking #FinancialServices #NASDAQ #Investing

0 · Reply

newsfile_corp Oct. 20 at 8:01 PM

https://nfne.ws/221039 $OFIX @BGandG_Law #Banking #FinancialServices #NASDAQ #Investing

0 · Reply

11thestate Oct. 15 at 6:08 PM

$OFIX stockholders filed a claim against Orthofix for concealing issues with its management team. You can join this case to be notified about potential recovery: https://11thestate.com/cases/orthofix-investor-case

0 · Reply

Market Cap	429.82M
Revenue (ttm)	799.49M
Net Income (ttm)	-126.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-15.76%
Debt to Equity Ratio	0.34

Volume	224,500
Avg Vol	434,612
Day's Range	N/A - N/A
Shares Out	39.18M
Stochastic %K	52%
Beta	0.80
Analysts	Strong Sell
Price Target	$22.30